A1 Refereed original research article in a scientific journal
Expression of EMMPRIN as a biomarker in nonodontogenic carcinomas: a histological study
Authors: Antisar, Ben Amer M.; Enas, Omar M.; Sahar, Elsheikh M.; Ahmed, Musrati S.
Publisher: Taylor & Francis
Publication year: 2026
Journal: Libyan Journal of Medicine
Article number: 2598896
Volume: 21
Issue: 1
ISSN: 1993-2820
eISSN: 1819-6357
DOI: https://doi.org/10.1080/19932820.2025.2598896
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Open Access publication channel
Web address : https://doi.org/10.1080/19932820.2025.2598896
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/506317532
EMMPRIN is a widely distributed cell surface glycoprotein that belongs to the immunoglobulin (Ig) superfamily. It induces the production of extracellular matrix metalloproteinases (MMPs) and plays an important role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF). The aim of the present work was to assess and compare the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in different oral nonodontogenic carcinomas. Fifty-four diagnosed cases of oral nonodontogenic carcinomas were selected, and biopsies were taken from the tumor tissue, fixed, processed, and cut into sections to be stained with hematoxylin and eosin (H&E) for routine histopathological examination. Immunohistochemistry was performed for EMMPRIN. All cases showed positive EMMPRIN expression with different intensities. The results were recorded and statistically analyzed using student t-test, Pearson correlation, test and ANOVA test. This study concluded that elevated EMMPRIN expression is correlated with tumor proliferation, angiogenesis, metastasis, and invasion.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
There were no funding agencies involved in our work.